nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—S100A4—pancreas—bile duct cancer	0.0439	0.0966	CbGeAlD
Trifluoperazine—EBPL—liver—bile duct cancer	0.0354	0.0779	CbGeAlD
Trifluoperazine—EBP—liver—bile duct cancer	0.0339	0.0746	CbGeAlD
Trifluoperazine—S100A4—liver—bile duct cancer	0.0279	0.0615	CbGeAlD
Trifluoperazine—CALM2—gall bladder—bile duct cancer	0.0274	0.0603	CbGeAlD
Trifluoperazine—EBPL—lymph node—bile duct cancer	0.0271	0.0597	CbGeAlD
Trifluoperazine—CALY—lymph node—bile duct cancer	0.0248	0.0546	CbGeAlD
Trifluoperazine—UGT1A4—liver—bile duct cancer	0.0245	0.054	CbGeAlD
Trifluoperazine—S100A4—lymph node—bile duct cancer	0.0214	0.0471	CbGeAlD
Trifluoperazine—TNNC1—lymph node—bile duct cancer	0.018	0.0397	CbGeAlD
Trifluoperazine—XDH—liver—bile duct cancer	0.0179	0.0394	CbGeAlD
Trifluoperazine—CALM3—pancreas—bile duct cancer	0.0161	0.0354	CbGeAlD
Trifluoperazine—SIGMAR1—pancreas—bile duct cancer	0.0144	0.0316	CbGeAlD
Trifluoperazine—CALM2—pancreas—bile duct cancer	0.0126	0.0278	CbGeAlD
Trifluoperazine—CALM1—pancreas—bile duct cancer	0.0126	0.0277	CbGeAlD
Trifluoperazine—CALM3—liver—bile duct cancer	0.0102	0.0225	CbGeAlD
Trifluoperazine—SIGMAR1—liver—bile duct cancer	0.00914	0.0201	CbGeAlD
Trifluoperazine—CALM2—liver—bile duct cancer	0.00803	0.0177	CbGeAlD
Trifluoperazine—CALM1—liver—bile duct cancer	0.008	0.0176	CbGeAlD
Trifluoperazine—CALM3—lymph node—bile duct cancer	0.00784	0.0173	CbGeAlD
Trifluoperazine—ADRA1A—liver—bile duct cancer	0.00754	0.0166	CbGeAlD
Trifluoperazine—SIGMAR1—lymph node—bile duct cancer	0.00701	0.0154	CbGeAlD
Trifluoperazine—CYP1A2—liver—bile duct cancer	0.00623	0.0137	CbGeAlD
Trifluoperazine—CALM2—lymph node—bile duct cancer	0.00616	0.0136	CbGeAlD
Trifluoperazine—CALM1—lymph node—bile duct cancer	0.00613	0.0135	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—bile duct cancer	0.00523	1	CrCbGaD
Trifluoperazine—ABCB1—pancreas—bile duct cancer	0.00502	0.0111	CbGeAlD
Trifluoperazine—HTR2A—liver—bile duct cancer	0.00487	0.0107	CbGeAlD
Trifluoperazine—HRH1—lymph node—bile duct cancer	0.00447	0.00985	CbGeAlD
Trifluoperazine—ABCB1—liver—bile duct cancer	0.00319	0.00703	CbGeAlD
Trifluoperazine—ABCB1—lymph node—bile duct cancer	0.00245	0.00539	CbGeAlD
Trifluoperazine—CALM1—Hemostasis—TGFB1—bile duct cancer	0.00018	0.000334	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—NRAS—bile duct cancer	0.000175	0.000323	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—NRAS—bile duct cancer	0.000175	0.000323	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—NRAS—bile duct cancer	0.000174	0.000321	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—KRAS—bile duct cancer	0.000173	0.00032	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NOS2—bile duct cancer	0.00017	0.000314	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFBR2—bile duct cancer	0.000169	0.000312	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—ERBB2—bile duct cancer	0.000169	0.000312	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—NRAS—bile duct cancer	0.000168	0.000311	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—NRAS—bile duct cancer	0.000168	0.000311	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—KRAS—bile duct cancer	0.000167	0.000309	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—KRAS—bile duct cancer	0.000167	0.000309	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EGFR—bile duct cancer	0.000165	0.000305	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NOS2—bile duct cancer	0.000164	0.000304	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NOS2—bile duct cancer	0.000164	0.000304	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFBR2—bile duct cancer	0.000163	0.000302	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000163	0.000302	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNAS—bile duct cancer	0.000163	0.000301	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—NRAS—bile duct cancer	0.000161	0.000297	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SMAD4—bile duct cancer	0.00016	0.000296	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—NRAS—bile duct cancer	0.00016	0.000296	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EGFR—bile duct cancer	0.000159	0.000295	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EGFR—bile duct cancer	0.000159	0.000295	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—HRAS—bile duct cancer	0.000159	0.000294	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—EGFR—bile duct cancer	0.000158	0.000292	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAS—bile duct cancer	0.000158	0.000291	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAS—bile duct cancer	0.000158	0.000291	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—KRAS—bile duct cancer	0.000156	0.000288	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SMAD4—bile duct cancer	0.000155	0.000286	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SMAD4—bile duct cancer	0.000155	0.000286	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—bile duct cancer	0.000154	0.000284	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—EGFR—bile duct cancer	0.000153	0.000283	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—EGFR—bile duct cancer	0.000153	0.000283	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—bile duct cancer	0.000152	0.000281	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000152	0.000281	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—KRAS—bile duct cancer	0.00015	0.000278	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—KRAS—bile duct cancer	0.00015	0.000278	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—KRAS—bile duct cancer	0.000149	0.000276	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—bile duct cancer	0.000149	0.000275	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—bile duct cancer	0.000149	0.000275	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAS—bile duct cancer	0.000148	0.000273	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—HRAS—bile duct cancer	0.000147	0.000272	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EGFR—bile duct cancer	0.000146	0.000271	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EGFR—bile duct cancer	0.000146	0.000269	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MMP9—bile duct cancer	0.000145	0.000267	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—KRAS—bile duct cancer	0.000144	0.000267	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—KRAS—bile duct cancer	0.000144	0.000267	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000142	0.000263	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—HRAS—bile duct cancer	0.000142	0.000263	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—HRAS—bile duct cancer	0.000142	0.000263	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—NRAS—bile duct cancer	0.000141	0.000261	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—NRAS—bile duct cancer	0.000139	0.000257	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—NRAS—bile duct cancer	0.000138	0.000256	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—ERBB2—bile duct cancer	0.000138	0.000256	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—KRAS—bile duct cancer	0.000138	0.000256	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—KRAS—bile duct cancer	0.000138	0.000254	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—NRAS—bile duct cancer	0.000136	0.000252	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—NRAS—bile duct cancer	0.000136	0.000251	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—ERBB2—bile duct cancer	0.000134	0.000248	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—ERBB2—bile duct cancer	0.000134	0.000248	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—HRAS—bile duct cancer	0.000132	0.000245	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EGFR—bile duct cancer	0.000129	0.000238	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—NRAS—bile duct cancer	0.000128	0.000237	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—HRAS—bile duct cancer	0.000128	0.000237	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—HRAS—bile duct cancer	0.000128	0.000237	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—ERBB2—bile duct cancer	0.000128	0.000236	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—HRAS—bile duct cancer	0.000127	0.000235	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—bile duct cancer	0.000127	0.000234	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EGFR—bile duct cancer	0.000126	0.000234	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EGFR—bile duct cancer	0.000126	0.000233	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—bile duct cancer	0.000125	0.000231	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—ERBB2—bile duct cancer	0.000125	0.000231	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EGFR—bile duct cancer	0.000124	0.00023	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—ERBB2—bile duct cancer	0.000124	0.00023	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EGFR—bile duct cancer	0.000124	0.000229	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—ERBB2—bile duct cancer	0.000124	0.000229	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—ERBB2—bile duct cancer	0.000124	0.000229	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—HRAS—bile duct cancer	0.000123	0.000227	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—HRAS—bile duct cancer	0.000123	0.000227	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—bile duct cancer	0.000122	0.000226	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—bile duct cancer	0.000122	0.000226	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—KRAS—bile duct cancer	0.000121	0.000225	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—bile duct cancer	0.000121	0.000223	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—bile duct cancer	0.000121	0.000223	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—KRAS—bile duct cancer	0.000119	0.000221	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—KRAS—bile duct cancer	0.000119	0.00022	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TGFB1—bile duct cancer	0.000119	0.00022	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAS—bile duct cancer	0.000118	0.000218	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—HRAS—bile duct cancer	0.000118	0.000217	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—KRAS—bile duct cancer	0.000117	0.000217	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—KRAS—bile duct cancer	0.000117	0.000216	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—HRAS—bile duct cancer	0.000117	0.000216	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EGFR—bile duct cancer	0.000117	0.000216	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—NRAS—bile duct cancer	0.000115	0.000213	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—bile duct cancer	0.000112	0.000208	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—bile duct cancer	0.000112	0.000207	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—NRAS—bile duct cancer	0.000111	0.000206	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—NRAS—bile duct cancer	0.000111	0.000206	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—KRAS—bile duct cancer	0.00011	0.000204	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—ERBB2—bile duct cancer	0.00011	0.000203	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—ERBB2—bile duct cancer	0.000108	0.000199	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—ERBB2—bile duct cancer	0.000108	0.000199	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—bile duct cancer	0.000107	0.000198	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—bile duct cancer	0.000106	0.000197	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—ERBB2—bile duct cancer	0.000106	0.000196	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—ERBB2—bile duct cancer	0.000106	0.000195	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—NRAS—bile duct cancer	0.000105	0.000195	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—bile duct cancer	0.000105	0.000194	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—bile duct cancer	0.000105	0.000193	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—HRAS—bile duct cancer	0.000103	0.000191	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—NRAS—bile duct cancer	0.000102	0.000188	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—NRAS—bile duct cancer	0.000102	0.000188	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—bile duct cancer	0.000102	0.000188	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—bile duct cancer	0.000102	0.000188	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—HRAS—bile duct cancer	0.000102	0.000188	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HRAS—bile duct cancer	0.000101	0.000187	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—bile duct cancer	0.000101	0.000187	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—bile duct cancer	0.000101	0.000187	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HRAS—bile duct cancer	9.97e-05	0.000184	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HRAS—bile duct cancer	9.94e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—KRAS—bile duct cancer	9.92e-05	0.000183	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—bile duct cancer	9.88e-05	0.000183	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—bile duct cancer	9.81e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NRAS—bile duct cancer	9.72e-05	0.00018	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—bile duct cancer	9.72e-05	0.00018	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—bile duct cancer	9.7e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—KRAS—bile duct cancer	9.59e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—KRAS—bile duct cancer	9.59e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—bile duct cancer	9.59e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—bile duct cancer	9.54e-05	0.000176	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—bile duct cancer	9.52e-05	0.000176	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NRAS—bile duct cancer	9.49e-05	0.000176	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NRAS—bile duct cancer	9.44e-05	0.000175	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NRAS—bile duct cancer	9.4e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NRAS—bile duct cancer	9.4e-05	0.000174	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—bile duct cancer	9.39e-05	0.000174	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HRAS—bile duct cancer	9.38e-05	0.000173	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—bile duct cancer	9.28e-05	0.000172	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—bile duct cancer	9.28e-05	0.000172	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—bile duct cancer	9.24e-05	0.000171	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—bile duct cancer	9.22e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—bile duct cancer	9.08e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KRAS—bile duct cancer	9.06e-05	0.000168	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—bile duct cancer	9.05e-05	0.000167	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—bile duct cancer	9.03e-05	0.000167	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—bile duct cancer	8.98e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—bile duct cancer	8.95e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—bile duct cancer	8.85e-05	0.000164	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—bile duct cancer	8.82e-05	0.000163	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—bile duct cancer	8.77e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—bile duct cancer	8.76e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—bile duct cancer	8.76e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—bile duct cancer	8.74e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—bile duct cancer	8.74e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—bile duct cancer	8.65e-05	0.00016	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—bile duct cancer	8.65e-05	0.00016	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—bile duct cancer	8.65e-05	0.00016	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—bile duct cancer	8.6e-05	0.000159	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—bile duct cancer	8.57e-05	0.000158	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—bile duct cancer	8.57e-05	0.000158	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—bile duct cancer	8.43e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—bile duct cancer	8.37e-05	0.000155	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NRAS—bile duct cancer	8.33e-05	0.000154	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NRAS—bile duct cancer	8.2e-05	0.000152	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NRAS—bile duct cancer	8.18e-05	0.000151	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—bile duct cancer	8.17e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—bile duct cancer	8.15e-05	0.000151	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—bile duct cancer	8.15e-05	0.000151	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—bile duct cancer	8.13e-05	0.00015	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—bile duct cancer	8.09e-05	0.00015	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—bile duct cancer	8.09e-05	0.00015	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—bile duct cancer	8.07e-05	0.000149	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NRAS—bile duct cancer	8.05e-05	0.000149	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NRAS—bile duct cancer	8.03e-05	0.000148	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—bile duct cancer	7.93e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—bile duct cancer	7.8e-05	0.000144	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—bile duct cancer	7.8e-05	0.000144	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—bile duct cancer	7.74e-05	0.000143	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—bile duct cancer	7.7e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—bile duct cancer	7.67e-05	0.000142	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—bile duct cancer	7.62e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—bile duct cancer	7.6e-05	0.000141	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—bile duct cancer	7.59e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—bile duct cancer	7.48e-05	0.000138	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—bile duct cancer	7.47e-05	0.000138	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—bile duct cancer	7.46e-05	0.000138	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—bile duct cancer	7.45e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—bile duct cancer	7.45e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—bile duct cancer	7.45e-05	0.000138	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—bile duct cancer	7.42e-05	0.000137	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—bile duct cancer	7.42e-05	0.000137	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—bile duct cancer	7.37e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—bile duct cancer	7.33e-05	0.000136	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—bile duct cancer	7.31e-05	0.000135	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—bile duct cancer	7.26e-05	0.000134	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—bile duct cancer	7.22e-05	0.000134	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—bile duct cancer	7.17e-05	0.000133	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—bile duct cancer	7.13e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—bile duct cancer	7.13e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—bile duct cancer	7.11e-05	0.000132	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—bile duct cancer	7.06e-05	0.000131	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—bile duct cancer	7.04e-05	0.00013	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—bile duct cancer	6.94e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—bile duct cancer	6.93e-05	0.000128	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—bile duct cancer	6.91e-05	0.000128	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—bile duct cancer	6.91e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—bile duct cancer	6.88e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—bile duct cancer	6.88e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NRAS—bile duct cancer	6.81e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—bile duct cancer	6.81e-05	0.000126	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—bile duct cancer	6.65e-05	0.000123	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—bile duct cancer	6.61e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NRAS—bile duct cancer	6.58e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NRAS—bile duct cancer	6.58e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—bile duct cancer	6.58e-05	0.000122	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—bile duct cancer	6.58e-05	0.000122	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—bile duct cancer	6.37e-05	0.000118	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—bile duct cancer	6.33e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—bile duct cancer	6.32e-05	0.000117	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—bile duct cancer	6.27e-05	0.000116	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—bile duct cancer	6.26e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—bile duct cancer	6.2e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—bile duct cancer	6.16e-05	0.000114	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—bile duct cancer	6.14e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—bile duct cancer	6.12e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—bile duct cancer	6.12e-05	0.000113	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—bile duct cancer	6.1e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—bile duct cancer	6e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—bile duct cancer	6e-05	0.000111	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—bile duct cancer	6e-05	0.000111	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—bile duct cancer	5.99e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—bile duct cancer	5.89e-05	0.000109	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—bile duct cancer	5.87e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—bile duct cancer	5.86e-05	0.000108	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—bile duct cancer	5.83e-05	0.000108	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—bile duct cancer	5.74e-05	0.000106	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—bile duct cancer	5.73e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—bile duct cancer	5.67e-05	0.000105	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—bile duct cancer	5.67e-05	0.000105	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—bile duct cancer	5.64e-05	0.000104	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—bile duct cancer	5.62e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—bile duct cancer	5.21e-05	9.63e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—bile duct cancer	5.04e-05	9.32e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—bile duct cancer	5.04e-05	9.32e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—bile duct cancer	4.98e-05	9.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—bile duct cancer	4.82e-05	8.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—bile duct cancer	4.82e-05	8.91e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—bile duct cancer	4.77e-05	8.81e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—bile duct cancer	4.61e-05	8.53e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—bile duct cancer	4.61e-05	8.53e-05	CbGpPWpGaD
